Documents FDA/Industry Workshop September 14-16, 2005 Critical Path Initiative: What it means for...

Slide 1FDA/Industry Workshop September 14-16, 2005 Critical Path Initiative: What it means for pharmaceutical industry statisticians Walter Offen, Lilly Brenda Gaydos, Lilly…

Documents OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP 1 OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP Are...

Slide 1 OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP 1 OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP Are Observational Studies Any Good? David Madigan, Columbia University on…